Recent Advances in ALK2 Inhibitors
Lisa Rooney, Chris Jones
Abstract
efficacy data available to demonstrate their suitability for treating a peripheral or CNS disease.
Topics & Concepts
Bone morphogenetic proteinActivin receptorFibrodysplasia ossificans progressivaIn vivoMedicineReceptorBioinformaticsPharmacologyCancer researchInternal medicineBiologyAnatomyGeneGeneticsOssificationHeterotopic Ossification and Related ConditionsMedical Imaging and Pathology StudiesTGF-β signaling in diseases